<SEC-DOCUMENT>0001292814-25-000516.txt : 20250224
<SEC-HEADER>0001292814-25-000516.hdr.sgml : 20250224
<ACCEPTANCE-DATETIME>20250221183145
ACCESSION NUMBER:		0001292814-25-000516
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20250331
FILED AS OF DATE:		20250224
DATE AS OF CHANGE:		20250221

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BRASKEM SA
		CENTRAL INDEX KEY:			0001071438
		STANDARD INDUSTRIAL CLASSIFICATION:	INDUSTRIAL ORGANIC CHEMICALS [2860]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14862
		FILM NUMBER:		25653619

	BUSINESS ADDRESS:	
		STREET 1:		RUA ETEND NO 1561
		CITY:			CAMARACI BAHIA BRAZIL
		STATE:			D5
		ZIP:			42810-000
		BUSINESS PHONE:		011551134439744

	MAIL ADDRESS:	
		STREET 1:		RUA ETENO NO 1561
		CITY:			CAMACARI BAHIA BRAZI
		STATE:			D5
		ZIP:			42810-000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	COPENE PETROQUIMICA DO NORDESTE SA
		DATE OF NAME CHANGE:	20000428
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>bak20250221_6k.htm
<DESCRIPTION>6-K
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>

<HR SIZE="2" NOSHADE ALIGN="LEFT" COLOR="Black" STYLE="width: 100%">
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 13.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<HR SIZE="1" NOSHADE ALIGN="CENTER" STYLE="width: 25%; color: black">

<P STYLE="font: 13.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM 6-K</B></P>

<P STYLE="font: 13.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>REPORT OF FOREIGN PRIVATE ISSUER PURSUANT
TO RULE 13A-16<BR>
OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><BR>
For the month of February, 2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: center"><B>(Commission File No. 1-14862 )</B></P>

<P STYLE="font: 13.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<HR SIZE="1" NOSHADE ALIGN="CENTER" STYLE="width: 25%; color: black">

<P STYLE="font: 13.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>BRASKEM S.A.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>(Exact Name as Specified in its Charter)</I></P>

<P STYLE="font: 13.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>N/A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>(Translation of registrant's name into English)</I></P>

<P STYLE="font: 13.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<HR SIZE="1" NOSHADE ALIGN="CENTER" STYLE="width: 25%; color: black">

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Rua Eteno, 1561, Polo Petroquimico de Camacari<BR>
Camacari, Bahia - CEP 42810-000 Brazil</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>(Address of principal executive offices)</I></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<HR SIZE="1" NOSHADE ALIGN="CENTER" STYLE="width: 25%; color: black">

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Indicate by check mark whether the registrant
files or will file annual reports under cover Form 20-F or Form 40-F.<BR>
<BR>
Form 20-F ___X___ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Form 40-F ______</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Indicate by check mark if the registrant is
submitting the Form 6-K<BR>
in paper as permitted by Regulation S-T Rule 101(b)(1). _____</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Indicate by check mark if the registrant is
submitting the Form 6-K<BR>
in paper as permitted by Regulation S-T Rule 101(b)(7). _____</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: center">Indicate by check mark whether the
registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant
to Rule 12g3-2(b) under the Securities Exchange Act of 1934.<BR>
<BR>
Yes ______ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; No ___X___</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">If &quot;Yes&quot; is marked, indicate below
the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _____.</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 3pt 0; text-align: justify; text-indent: 206.65pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 11pt/115% Tahoma, Helvetica, Sans-Serif; margin: 3pt 0; text-align: left; color: #7F7F7F">&nbsp;<IMG SRC="bak202502216k_001.jpg" ALT=""></P>

<P STYLE="font: 11pt/115% Tahoma, Helvetica, Sans-Serif; margin: 3pt 0; text-align: center; color: #7F7F7F"></P>

<P STYLE="font: 12pt/16pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><B>NOTICE ON RELATED-PARTY TRANSACTIONS</B></P>

<P STYLE="font: 12pt/16pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 12pt/16pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><B>S&atilde;o Paulo, February 21, 2025</B> -
Braskem S.A. (&#8220;Braskem&#8221;), in compliance with article 33, XXXII of CVM Resolution 80/2022, hereby informs its shareholders
and the market in general of the following transaction between related parties:</P>

<P STYLE="font: 12pt/16pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 36%; border: Black 1pt solid; padding: 6pt 5.65pt; background-color: #D9D9D9; text-align: justify; line-height: 115%"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt; line-height: 115%">Parties</FONT></TD>
    <TD STYLE="width: 64%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 6pt 2.85pt 6pt 5.65pt; text-align: justify; line-height: 115%"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt; line-height: 115%">Braskem and Petr&oacute;leo Brasileiro S.A. &#8211; Petrobras (&quot;Petrobras&quot;).</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 6pt 5.65pt; background-color: #D9D9D9; text-align: justify; line-height: 115%"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt; line-height: 115%">Relationship with the issuer</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 6pt 2.85pt 6pt 5.65pt; text-align: justify; line-height: 115%"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt; line-height: 115%">Petrobras is a Shareholder with Significant Influence over Braskem.</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 6pt 5.65pt; background-color: #D9D9D9; text-align: justify; line-height: 115%"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt; line-height: 115%">Purpose</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 6pt 2.85pt 6pt 5.65pt; text-align: justify; line-height: 115%"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt; line-height: 115%">Spot purchase and sale contract for polymer grade propylene, from the Alberto Pasqualini Refinery (&#8220;REFAP&#8221;), between Braskem, as buyer, and Petrobras, as seller, which reached a new amount of R$50 million on 02/12/2025.</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 36%; border: Black 1pt solid; padding: 6pt 5.65pt; background-color: #D9D9D9; text-align: justify; line-height: 115%"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt; line-height: 115%">Key Terms and Conditions</FONT></TD>
    <TD STYLE="width: 64%; border-top: 1pt windowtext solid; border-right: 1pt windowtext solid; border-bottom: 1pt windowtext solid; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 6pt 2.85pt 6pt 5.65pt; text-align: justify">On 01/07/2022, the signing
of 5 propylene contracts between Petrobras and Braskem was announced relating to (i) Planalto de Paul&iacute;nia Refinery (REPLAN), (ii)
Henrique Lage Refinery (REVAP), (iii) Presidente Get&uacute;lio Vargas Refinery (REPAR), (iv) Capuava Refinery (RECAP) and (v) Duque de
Caxias Refinery (REDUC) through of Communication on Transactions with Related Parties.</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 6pt 2.85pt 6pt 5.65pt; text-align: justify">In these contracts, there
are clauses that provide flexibility for negotiating prices and reallocating quantities between contracts signed between the parties.</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 6pt 2.85pt 6pt 5.65pt; text-align: justify">On 06/15/2023, the first
spot purchase contract was signed by Braskem and sale by Petrobras of polymer grade propylene from REFAP, whose sales were the subject
of a Related Party Transaction Communication on 09/26/2023.</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 6pt 2.85pt 6pt 5.65pt; text-align: justify">On 09/29/2023, the second
spot purchase contract was signed by Braskem and sale by Petrobras of polymer grade propylene from REFAP (&ldquo;Second REFAP Contract&rdquo;),
the sales of which were the subject of a Communication on Transaction with Related Parties on 11/13/2023.</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 6pt 2.85pt 6pt 5.65pt; text-align: justify">Subsequently, quantities
of propylene from the REPAR polymer grade propylene purchase and sale contract between Braskem and Petrobras (&ldquo;REPAR Contract&rdquo;)
were reallocated to the Second REFAP Contract, whose sales were the subject of a Communication on Transaction with Related Parties on
12/18/2023.</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 6pt 2.85pt 6pt 5.65pt; text-align: justify">On 02/09/2024, the Third
Contract for spot purchase by Braskem and sale by Petrobras of polymer grade propylene from REFAP (&ldquo;Third REFAP Contract&rdquo;)
was signed, effective from 02/09/2024 until 03/31/2024, which was extended until 04/30/24 and subsequently until 06/30/2024. The Third
REFAP Contract initially included a sale of polymer grade propylene estimated at 285 tons.</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 6pt 2.85pt 6pt 5.65pt; text-align: justify">Quantities of propylene
from the REPAR Contract were reallocated to the Third REFAP Contract, reaching a new amount of R$50 million, on 03/28/2024, which was
the subject of a Communication on Transaction with Related Parties on 04/09/2024.</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 6pt 2.85pt 6pt 5.65pt; text-align: justify">The Third REFAP Contract
reached a new amount of R$50 million on 06/27/2024, which was the subject of a Communication on Transaction with Related Parties on 07/08/2024.</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 6pt 2.85pt 6pt 5.65pt; text-align: justify">On 07/01/2024, the Fourth
Contract for spot purchase by Braskem and sale by Petrobras of polymer grade propylene from REFAP was signed, effective until 08/31/2024,
covering a volume of propylene of 300 tons. A new amount of R$50 million was reached on 08/22/2024, which was the subject of a Communication
on Transaction with Related Parties on 09/02/2024.</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 6pt 2.85pt 6pt 5.65pt; text-align: justify">On 08/30/2024, the Fifth
Contract for spot purchase by Braskem and sale by Petrobras of polymer grade propylene from REFAP was signed, effective until 10/31/2024,
covering a volume of propylene of 500 tons. A new amount of R$50 million was reached on 09/28/2024, which was the subject of a Communication
on Transaction with Related Parties on 10/08/2024.</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 6pt 2.85pt 6pt 5.65pt; text-align: justify">On 12/27/2024, the Sixth
spot purchase contract by Braskem and sale by Petrobras of polymer grade propylene from REFAP was signed, subject to the Communication
on transaction between Related Parties effective from 01/01/2025 until 03/31/2025, covering a volume of 1,300 tons.</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 6pt 2.85pt 6pt 5.65pt; text-align: justify">In this context, quantities
of propylene from the REPAR polymer grade propylene purchase and sale contract between Braskem and Petrobras (&ldquo;REPAR Contract&rdquo;)
were also reallocated to the Sixth REFAP Contract, resulting in a new amount of R$50 million, as detailed below:</P>
<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin-top: 6pt; margin-bottom: 6pt; text-align: center">&nbsp;<IMG SRC="bak202502216k_002.jpg" ALT=""></P>
<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 6pt 2.85pt 6pt 5.65pt; text-align: justify">Net accumulated amount of the Sixth REFAP Contract until 02/12/2025: R$50.2 million, of which R$4.8 million are specific to the
Sixth REFAP Contract and R$45.4 million from the reallocation of resources available in the REPAR Contract.</P>
</TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 6pt 5.65pt; background-color: #D9D9D9; text-align: justify; line-height: 115%"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt; line-height: 115%">Date of signing of the Amendment</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 6pt 2.85pt 6pt 5.65pt; text-align: justify; line-height: 115%"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt; line-height: 115%">Agreement signed on 01/01/2025, valid until 03/31/2025, having reached a new amount of R$50 million on 02/12/2025.</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 6pt 5.65pt; background-color: #D9D9D9; text-align: justify; line-height: 115%"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt; line-height: 115%">Possible participation of the counterparty, its partners, or managers in the issuer's decision-making process or negotiation of the transaction as representatives of the issuer</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 6pt 2.85pt 6pt 5.65pt; text-align: justify; line-height: 115%"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt; line-height: 115%">The counterparty and its partners and managers have not participated in Braskem&#8217;s decision process or the negotiations of the mentioned agreements.</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 6pt 5.65pt; background-color: #D9D9D9; text-align: justify; line-height: 115%"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt; line-height: 115%">Detailed justification of the reasons why the issuer's management considers that the transaction has complied with commutative conditions or provides for an appropriate reverse payment</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 6pt 2.85pt 6pt 5.65pt; text-align: justify; line-height: 115%"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt; line-height: 115%">The transaction was made regarding the purchase of propylene referenced in international prices.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt/16pt Calibri, Helvetica, Sans-Serif; margin: 0 14.2pt 0 0; text-align: justify"><B>&nbsp;</B></P>



<P STYLE="font: 11pt/115% Tahoma, Helvetica, Sans-Serif; margin: 3pt 0; text-align: center; color: #7F7F7F">&nbsp;</P>

<P STYLE="font: 11pt/115% Tahoma, Helvetica, Sans-Serif; margin: 3pt 0; text-align: center; color: #7F7F7F"></P>

<P STYLE="font: 11pt/115% Tahoma, Helvetica, Sans-Serif; margin: 3pt 0; text-align: center; color: #7F7F7F">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 13.5pt Times New Roman, Times, Serif; text-align: center; margin-right: 0; margin-left: 0"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: left; text-indent: 0.25in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">Date: February 21, 2025</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>BRASKEM S.A.</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 46%; font: 12pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 43%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Felipe Montoro Jens</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Felipe Montoro Jens</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 13.5pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>DISCLAIMER ON FORWARD-LOOKING STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/11.2pt Times New Roman, Times, Serif; margin: 0 0 3pt; text-align: justify; background-color: white">This
report on Form 6-K may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of
1995. These statements are statements that are not historical facts, and are based on our management&rsquo;s current view and estimates
of future economic and other circumstances, industry conditions, company performance and financial results, including any potential
or projected impact of the geological event in Alagoas and related legal proceedings and of COVID-19 on our business, financial
condition and operating results. The words &ldquo;anticipates,&rdquo; &ldquo;believes,&rdquo; &ldquo;estimates,&rdquo; &ldquo;expects,&rdquo;
&ldquo;plans&rdquo; and similar expressions, as they relate to the company, are intended to identify forward-looking statements.
Statements regarding the potential outcome of legal and administrative proceedings, the implementation of principal operating and
financing strategies and capital expenditure plans, the direction of future operations and the factors or trends affecting our
financial condition, liquidity or results of operations are examples of forward-looking statements. Such statements reflect the
current views of our management and are subject to a number of risks and uncertainties, many of which are outside of the our control.
There is no guarantee that the expected events, trends or results will actually occur. The statements are based on many assumptions
and factors, including general economic and market conditions, industry conditions, and operating factors. Any changes in such
assumptions or factors, including the projected impact of the geological event in Alagoas and related legal proceedings and the
unprecedented impact of COVID-19 pandemic on our business, employees, service providers, stockholders, investors and other stakeholders,
could cause actual results to differ materially from current expectations. Please refer to our annual report on Form 20-F for the
year ended December 31, 2019 filed with the SEC, as well as any subsequent filings made by us pursuant to the Exchange Act, each
of which is available on the SEC&rsquo;s website (www.sec.gov), for a full discussion of the risks and other factors that may impact
any forward-looking statements in this presentation.</P>
<HR SIZE="2" NOSHADE ALIGN="LEFT" COLOR="Black" STYLE="width: 100%">
<P STYLE="font: 11pt Tahoma, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #7F7F7F"><B>&nbsp;</B></P>

<P STYLE="font: 11pt/150% Tahoma, Helvetica, Sans-Serif; margin: 6pt 0 0; text-align: justify; color: #7F7F7F">&nbsp;</P>

<P STYLE="font: 11pt/150% Tahoma, Helvetica, Sans-Serif; margin: 12pt 0 0; text-align: justify; color: #7F7F7F">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>bak202502216k_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bak202502216k_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !3 (<# 2(  A$! Q$!_\0
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M\1_V);K/<7*_ZQXDS''Z[FSV[UYSXJO+O7]<\,76GC[->75H#",XV/N(X/\
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C %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>bak202502216k_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bak202502216k_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !Z >$# 2(  A$! Q$!_\0
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M">#_ /H5-#_\%T/_ ,31_P ()X/_ .A4T/\ \%T/_P 30!T%%<__ ,()X/\
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M5-#_ /!=#_\ $T =!17/_P#"">#_ /H5-#_\%T/_ ,31_P ()X/_ .A4T/\
M\%T/_P 30!T%%<__ ,()X/\ ^A4T/_P70_\ Q-8=KX+\*MXZU:W;PUHQ@33+
M)TC-A%M5FEN@Q VX!(503WVCTH [RBN?_P"$$\'_ /0J:'_X+H?_ (FC_A!/
M!_\ T*FA_P#@NA_^)H Z"BN?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA
M_P#@NA_^)H Z"BN?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^
M)H Z"BN?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^)H Z"BN?
M_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^)H Z"BN?_P"$$\'_
M /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^)H Z"BN?_P"$$\'_ /0J:'_X
M+H?_ (FC_A!/!_\ T*FA_P#@NA_^)H Z"BN?_P"$$\'_ /0J:'_X+H?_ (FC
M_A!/!_\ T*FA_P#@NA_^)H Z"BN?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\
MT*FA_P#@NA_^)H Z"BN?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@
MNA_^)H Z"BN?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^)H Z
M"BN?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^)H Z"BN?_P"$
M$\'_ /0J:'_X+H?_ (FL^WT+1]$^(>E_V3I5C8>=I5]YGV2W2+?B6TQG:!G&
M3U]30!V%%%% '/V?_)0]9_[!5A_Z-NZZ"N?L_P#DH>L_]@JP_P#1MW704 %%
M%% &1?\ BKP[I5VUIJ.O:79W*@%H;B\CC< ],AB#5W3]2L-6M1=:=>VUY;DE
M1+;RK(A(ZC*DBN4^)O\ R ])_P"PW8_^CA4FNW>L3^/M)T2QU:33[.XL)[B=
MHH8WD)1XPNTNK 'YL<@C!/&<$ '8T5YCJ_BW5;;54NM.N]1NK&+6(M.G/V:V
M2S ,@C=,D^<9 3]]?ESV I-4UOQ*MMXWU.VUQH8]"N#]EM1;1%758DD97)4L
M0<G&""">I&  #T^BN#NM=U>V\56\VH75W8:+<O;)9-%;1RV\A<#<D[8+HQ8[
M5(VKR,YY%9]YXMU5-;M+JPNM0NM-EUM--=FMK>.SVM)Y;*N3Y[.I_C^X2#P!
MT /3*ANKRUL8//N[F&WAW*OF3.$7+$ #)[DD >YKD/#MSK?B8WFJ?VU+901Z
MA/:I8I;Q,BQ1N4R2R[_,.,YW;1Q\IKC+-+O3/AMJUW_:$MW_ ,3\Q"&[MX)(
MP?MZJ7QY?WCDGG@'E0N!0![117GEWK&O7^G>+-9M-8;3UT2>>&WM!!&\<ODH
M&)E+*6^8DXVLN!@\TV+5O$/B#7]0AM=8DTNWBT:UO8X8[>)V6:0.<$NI^7Y1
MD8SQP5YR >BT5B^$-7FU[P?I&JW"JL]W:1RR!>FXCG'MG-;5 !7/^(?^0YX3
M_P"PK)_Z175=!7/^(?\ D.>$_P#L*R?^D5U0!T%%%% !1110 4444 %%%% !
M1110 4444 %%%% !7/V?_)0]9_[!5A_Z-NZZ"N?L_P#DH>L_]@JP_P#1MW0!
MT%%%% %:]U"RTV%9K^\M[6)W$:O/*J L>B@D]3Z59KS/Q])::]XE7P_=QWLE
MI::=-/(UK8SW.VXF4QP[O*1MI5?,8$^U)9>*M7UW3?!$=GJ+6%QJ33V^H,85
M=UDAB;>,./E;<AQD=QD$<$ ]-HKRVZ\3^(8GET>#5@;FW\1P::-0EMXV,D,L
M6_#* %+J3CY0N<#IS1KOB7Q#HD/B73(-6>YN;"73FMKVXMXMRK<2A&1PBJIX
M!QA0<,>X!H ]2HKB[F;6%\3:=X7CUZZ0R6<U]<:@8H/.<*ZH(T7R]@&6R<J3
M@=>]8EQXNU[2_#UWJ,MVMY)HNMM831+$JMJ41V@!0!Q*-X/RX!*'(] #TF2\
MM8;J"UEN84N+C=Y,3. \FT9;:.IP",XZ5-7G.EZI?7VK>!;N\NK6[DU**]N6
M=((R(@45ECC?;N4*#M)SEL'.>@S-/UOQ;/X>\+ZL_B+=+K%_]ADA:RB\N-")
M,., -Y@\ON=O/W>.0#UFBO-T\4:C90Z_I=YJUS+<66J0V=K<QVD3W,XE17$:
MJ L>_E@&(VX&2*P->U'6=6\'^)M/U&\U"%]+U2R1//CMA,Z2/"P67RPT?REL
M@IC.!GN* /9Z@O+RUT^TDN[VYAMK:,9>:9PB*/<G@5P6K:MX@7Q2?#6GSZS.
M+2P2YDN[2.R\^5W=@-XFV1[!M_@4$GN._8^'9=5G\/V4FN6ZV^J&/_28T*D!
MAQGY21SUX)ZT 06GC#PS?W4=K9^(](N+B4[8XH;Z-W<^@ ;)K:KS[PU>G3)/
MB'?B(RFVU.681CJVVWC./QQ4::IX@M+#PKJL^MR70UR>&"XM5MXECA\Z-G#0
MD+N^3 ^^7R >E 'HM4]4U2ST;3I;_4)O)M8BH=]I;&Y@HX )ZD5YKX7N)O#_
M (&UF_EUV]RVK7-O$IMHI3YAN2N4154F1R>YV@G.W Q537-8U:[\->,-)U3[
M;BQ;3Y(3?K;B?$DHR&-N?+(RF1CGGF@#UNXO+6T,(N;F&$SR"*+S'"^8YR0J
MYZL<'@<\437EK;SP037,,<UPQ6&-W :0@9(4'J0 3QV%8/CS2YM4\'WJV8_T
M^UVWEF1U$T1#KCW.W'XUS^FZU:^*/$[^)$FCCTW1M'5XY'RZQS7""1R0,9VQ
MJ@(X/S$4 >@RRI#"\LAPB*68XZ =:@T[4+75M-MM1L9?-M;F-989-I7<I&0<
M$ C\:\XL?$NLRZQ:VMQ+J<VG:KI=U.CZA;VT0)15(:(1'>JD/]V3GD<GFIO
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M>X(!'N*=-#%<P203Q)+#*I22-U#*ZD8((/!!':GT4 -1$BC6.-%1% 5548
MZ "G444 %<_9_P#)0]9_[!5A_P"C;NN@KG[/_DH>L_\ 8*L/_1MW0!T%%%%
M!1110 4444 %%%% 'B\YE?X4Z5?1HLE[>>)EN7$CE0\IO6&"<$@< 9P<8Z&M
MFTT.;Q3?^/;+4632]3O(H+22WMV\V-$"$QS;B%\S=EAT4@+@UTNE^#+>"TO-
M-U"..XT\:J=1L565PT9+"0 XQ]V0MCD@C&:T[_POHVIWD]W>6?F3SVZVTKB1
MUW1J^]1@$#(;D-U'8T 8N@ZM>P>)DT'7=)L(-4%@9+>]L3NCGA5@"N" T>"R
M_+R.N#2:K<:W?_$$Z'8ZU)IMF-)%VQBMXI'\SS648+J0!TR,'IQC.:T_#7A6
MV\/PB62>:_U-X_+FU"YDDDDD4'(4%V8JO^R#CC/6M/\ LNS&L'5O)_TXVXMC
M+N/^KW;MN,XZG.<9H \ZT3Q/XADM/!FL7VJ"=-<N#:W%DENB1(/+<JZG&_=E
M,G+$')P!5;0;E[K5O!LDB0JPUG5TQ#"D2X"S <* ,X')ZGJ<FO08?"NBP66E
M6<5EM@TJ4362^:Y\I\,,YSD\,W7/6EM?"VC6<EG);V>QK*>:XMSYKG9)-N\P
M\GG.YN#D#/&* /-_#>HOIUEX0<0Q2J#K4K Q(7.R1R KD%ESWVD9[YK9MM;\
M00:1X5\0S:Q]J36KJVCGT_R8Q#&D_3RV"A\ID?>9LX-=?:>%]&L6L&MK/8;
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M[][=XQME3'?KG.1TQSH?8_&'_0=T/_P33?\ R50!T%%<_P#8_&'_ $'=#_\
M!--_\E4?8_&'_0=T/_P33?\ R50!T%%<_P#8_&'_ $'=#_\ !--_\E4?8_&'
M_0=T/_P33?\ R50!T%%<_P#8_&'_ $'=#_\ !--_\E4?8_&'_0=T/_P33?\
MR50!T%%<_P#8_&'_ $'=#_\ !--_\E4?8_&'_0=T/_P33?\ R50!T%%<_P#8
M_&'_ $'=#_\ !--_\E4?8_&'_0=T/_P33?\ R50!T%%<_P#8_&'_ $'=#_\
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MNA_^":;_ .2J .@HKG_L?C#_ *#NA_\ @FF_^2J/L?C#_H.Z'_X)IO\ Y*H
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MMW705S]G_P E#UG_ +!5A_Z-NZ .@HHHH **** "BBB@ HHHH **** "BBN
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MT^R@BYE>XBU![F6XF8Y9Y-T*<GKG)[#&*Z6BB@ HHHH **** "BBB@ HHHH
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M_P#!%>__ !FN@HH Y_\ X3+2_P#GUUS_ ,$5[_\ &:/^$RTO_GUUS_P17O\
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MS1_PF6E_\^NN?^"*]_\ C-=!10!S_P#PF6E_\^NN?^"*]_\ C-'_  F6E_\
M/KKG_@BO?_C-=!10!S__  F6E_\ /KKG_@BO?_C-'_"9:7_SZZY_X(KW_P",
MUT%% '/_ /"9:7_SZZY_X(KW_P",T?\ "9:7_P ^NN?^"*]_^,UT%% '/_\
M"9:7_P ^NN?^"*]_^,T?\)EI?_/KKG_@BO?_ (S7044 <_\ \)EI?_/KKG_@
MBO?_ (S1_P )EI?_ #ZZY_X(KW_XS7044 <__P )EI?_ #ZZY_X(KW_XS1_P
MF6E_\^NN?^"*]_\ C-=!10!S_P#PF6E_\^NN?^"*]_\ C-4[;4H]9\=:=<6E
DKJ2P6^F7B2R76G3VRAGEMBH!E1020CG ST-=910 4444 ?_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
